Evaluating the 8‐Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort
Brain and Behavior · 2026
DOI: 10.1002/brb3.71684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Joshua David und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas, USA. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Cognition, Brain, Cognitive Dysfunction. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Mounting evidence suggests beta amyloid (Aβ) is not the sole initiating driver of cognitive decline in Alzheimer's disease (AD). This study explores whether there is an association between cognitive decline over eight years and Aβ.
Methods
Data from 48 participants in the Dallas Lifespan Brain Study (DLBS) were analyzed in the present study. Prior to selection, participants were classified as Aβ + or Aβ − based on global Aβ deposition. All 24 Aβ + participants with complete data for the purposes of the present study were sex‐ and age‐matched with an Aβ − participant and assorted into two respective Aβ groups. Cognitive decline across episodic memory, working memory, processing speed, and reasoning was then compared between the two groups over an 8‐year observation period.
Results
An association between cognitive decline over 8 years and the Aβ group was observed in reasoning but not across episodic memory, working memory, and processing speed. Still, there were differences between the two groups that reached significance on an episodic memory task ( p = 0.035) and trended toward significance on an encompassing episodic memory composite ( p = 0.057). Post‐hoc comparisons revealed these differences were only significant at epoch 1. Broad declines in cognition were also found over the observation period, irrespective of Aβ group.
Conclusion
Our results contribute to the mounting evidence that suggests Aβ is not the sole initiating driver of cognitive decline in AD. However, the present study has limitations, including a relatively small sample size that must be accounted for when considering the null findings to prevent overinterpretation. Future work should validate our results in larger, similarly controlled samples and model additional AD biomarkers and risk factors to explore different mechanisms for cognitive decline in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas, USA.
- Psychology Department, Bradley University, Peoria, Illinois, USA.
- Center For Vital Longevity, Dallas, Texas, USA.
ORCID-Profile: Joshua David, Isabella Torres, Evan Smith, Ekarin Pongpipat, Denise Park
Zitieren
APA
David, J., Torres, I., Smith, E., Pongpipat, E., & Park, D. (2026). Evaluating the 8‐Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort. Brain and Behavior. https://doi.org/10.1002/brb3.71684
Vancouver
David J, Torres I, Smith E, Pongpipat E, Park D. Evaluating the 8‐Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort. Brain and Behavior. 2026. doi:10.1002/brb3.71684
BibTeX
@article{David2026,
author = {David, Joshua and Torres, Isabella and Smith, Evan and Pongpipat, Ekarin and Park, Denise},
title = {Evaluating the 8‐Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71684}
}
EUVIMED